Hisamitsu Pharmaceutical Co Top Insiders
HTSUFDelisted Stock | USD 30.31 0.00 0.00% |
Hisamitsu Pharmaceutical employs about 2.8 K people. The company is managed by 10 executives with a total tenure of roughly 57 years, averaging almost 5.0 years of service per executive, having 278.4 employees per reported executive. Examination of Hisamitsu Pharmaceutical's management performance can provide insight into the company performance.
Kyu Saito Chairman Executive Officer, Director of International Business, Chairman of Subsidiaries, Director |
Kazuhide Nakatomi President President, COO and Executive VP |
Hisamitsu |
Hisamitsu Pharmaceutical Management Team Effectiveness
The company has return on total asset (ROA) of 0.0212 % which means that it generated a profit of $0.0212 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0504 %, meaning that it generated $0.0504 on every $100 dollars invested by stockholders. Hisamitsu Pharmaceutical's management efficiency ratios could be used to measure how well Hisamitsu Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Hisamitsu Pharmaceutical Workforce Comparison
Hisamitsu Pharmaceutical Co is one of the top stocks in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 81,639. Hisamitsu Pharmaceutical holds roughly 2,784 in number of employees claiming about 3% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09. Hisamitsu Pharmaceutical Notable Stakeholders
A Hisamitsu Pharmaceutical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Hisamitsu Pharmaceutical often face trade-offs trying to please all of them. Hisamitsu Pharmaceutical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Hisamitsu Pharmaceutical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kyu Saito | Executive Officer, Director of International Business, Chairman of Subsidiaries, Director | Profile | |
Kazuhide Nakatomi | President, COO and Executive VP | Profile | |
Koji Takiyama | Executive Officer, Manager of President's Office | Profile | |
Shinichi Murayama | Executive Officer, Manager of President's Office in Kyushu Headquarters, Director | Profile | |
Shinichiro Takao | General Manager of IR Department, Treasurer and Director | Profile | |
Nobuo Tsutsumi | Executive Officer, Director of Legal Affairs, Director | Profile | |
Kosuke Sugiyama | Senior Managing Director, Executive Officer, Director of Human Resource | Profile | |
Mitsutoshi Tsuruta | Ex Division | Profile | |
Masaya Okuno | OTC Division | Profile | |
Mitsumasa Kabashima | Pres Ltd | Profile |
About Hisamitsu Pharmaceutical Management Performance
The success or failure of an entity such as Hisamitsu Pharmaceutical often depends on how effective the management is. Hisamitsu Pharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Hisamitsu management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Hisamitsu management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. Hisamitsu Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2784 people.
Hisamitsu Pharmaceutical Workforce Analysis
Traditionally, organizations such as Hisamitsu Pharmaceutical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Hisamitsu Pharmaceutical within its industry.Hisamitsu Pharmaceutical Manpower Efficiency
Return on Hisamitsu Pharmaceutical Manpower
Revenue Per Employee | 43.2M | |
Revenue Per Executive | 12B | |
Net Income Per Employee | 3.5M | |
Net Income Per Executive | 965.8M | |
Working Capital Per Employee | 48.1M | |
Working Capital Per Executive | 13.4B |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Hisamitsu Pink Sheet
If you are still planning to invest in Hisamitsu Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hisamitsu Pharmaceutical's history and understand the potential risks before investing.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |